Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protein C concentrate in severe sepsis with contraindications to activated protein C
2011-004834-32Phase 3Completed
- Sponsor
- Fondazione Centro San Raffaele
- Start
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in sepsis comparing Protein C concentrate with Placebo (2 arms). Primary endpoint: 30-day mortality or prolonged intensive care stay. Started Mar 2012; status: completed.
02
Drugs
Protein C concentrate
03
Conditions
sepsis
Beyond the preview
Go deeper on 2011-004834-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004834-32.